Quantum-Si incorporated (QSI)
NASDAQ: QSI · IEX Real-Time Price · USD
1.650
+0.040 (2.48%)
At close: Apr 26, 2024, 4:00 PM
1.620
-0.030 (-1.82%)
After-hours: Apr 26, 2024, 5:37 PM EDT
Quantum-Si incorporated Market Cap
Quantum-Si incorporated has a market cap or net worth of $233.92 million as of April 26, 2024. Its market cap has increased by 5.80% in one year.
Market Cap
233.92M
Enterprise Value
-8.51M
1-Year Change
5.80%
Ranking
Category
Stock Price
$1.65
Market Cap Chart
Since September 4, 2020, Quantum-Si incorporated's market cap has increased from $130.70M to $233.92M, an increase of 78.98%. That is a compound annual growth rate of 17.32%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 26, 2024 | 233.90M | 2.50% |
Apr 25, 2024 | 228.20M | -3.63% |
Apr 24, 2024 | 236.80M | -1.74% |
Apr 23, 2024 | 241.00M | 4.92% |
Apr 22, 2024 | 229.70M | 3.19% |
Apr 19, 2024 | 222.60M | 3.97% |
Apr 18, 2024 | 214.10M | -1.29% |
Apr 17, 2024 | 216.90M | -6.71% |
Apr 16, 2024 | 232.50M | -1.19% |
Apr 15, 2024 | 235.30M | -1.79% |
Apr 12, 2024 | 239.60M | -7.13% |
Apr 11, 2024 | 258.00M | -0.54% |
Apr 10, 2024 | 259.40M | -3.17% |
Apr 9, 2024 | 267.90M | 3.84% |
Apr 8, 2024 | 258.00M | - |
Apr 5, 2024 | 258.00M | 1.10% |
Apr 4, 2024 | 255.20M | -2.18% |
Apr 3, 2024 | 260.90M | 2.23% |
Apr 2, 2024 | 255.20M | -2.71% |
Apr 1, 2024 | 262.30M | -6.09% |
Mar 28, 2024 | 279.30M | 4.26% |
Mar 27, 2024 | 267.90M | 6.78% |
Mar 26, 2024 | 250.90M | -0.59% |
Mar 25, 2024 | 252.40M | -0.55% |
Mar 22, 2024 | 253.80M | -5.79% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
XBiotech | 239.65M |
Verastem | 237.27M |
Utah Medical Products | 236.59M |
Adlai Nortye | 236.42M |
Conduit Pharmaceuticals | 234.04M |
Foghorn Therapeutics | 233.69M |
Aldeyra Therapeutics | 233.50M |
AC Immune | 233.11M |